Mineralys Therapeutics, Inc. (MLYS)
NASDAQ: MLYS · Real-Time Price · USD
35.93
+1.13 (3.25%)
At close: Sep 8, 2025, 4:00 PM
36.95
+1.02 (2.84%)
Pre-market: Sep 9, 2025, 4:06 AM EDT

Mineralys Therapeutics Balance Sheet

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Jun '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Cash & Equivalents
101.79114.0949.387.710.611.41
Short-Term Investments
223.1384.1187.2622.41--
Cash & Short-Term Investments
324.92198.19236.57110.1110.611.41
Cash Growth
4.44%-16.22%114.85%937.60%653.16%-
Prepaid Expenses
10.357.1612.542.70.460.06
Restricted Cash
----0.05-
Total Current Assets
335.27205.35249.1112.8111.121.47
Property, Plant & Equipment
0.020.05----
Long-Term Investments
--2.48---
Long-Term Deferred Charges
0.30.4-1.60-
Other Long-Term Assets
0.130.10.050.03-0.02
Total Assets
335.72205.9251.64114.4411.131.49
Accounts Payable
3.160.480.61.910.760.53
Accrued Expenses
19.0114.179.886.164.290.05
Short-Term Debt
-----4.5
Total Current Liabilities
22.1714.6510.488.075.055.08
Total Liabilities
22.1714.6510.488.075.055.08
Common Stock
0.010.010000.01
Additional Paid-In Capital
701.55493.77365.860.540.09-
Retained Earnings
-388-302.52-124.71-52.81-23.01-3.6
Total Common Equity
313.55191.26241.15-52.27-22.93-3.6
Shareholders' Equity
313.55191.26241.15106.386.07-3.6
Total Liabilities & Equity
335.72205.9251.64114.4411.131.49
Total Debt
-----4.5
Net Cash (Debt)
324.92198.19236.57110.1110.61-3.09
Net Cash Growth
4.44%-16.22%114.85%937.60%--
Net Cash Per Share
5.954.086.5421.312.13-0.67
Filing Date Shares Outstanding
66.349.8449.6340.865.444.63
Total Common Shares Outstanding
65.7349.8241.136.425.444.63
Working Capital
313.1190.71238.62104.746.07-3.62
Book Value Per Share
4.773.845.86-8.14-4.21-0.78
Tangible Book Value
313.55191.26241.15-52.27-22.93-3.6
Tangible Book Value Per Share
4.773.845.86-8.14-4.21-0.78
Updated Aug 12, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q